
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Apelix is a common drug that is widely used in a variety of health management fields. Knowing the right dosage can ensure that your medication is working as well as it should. The ···【more】
Article source:Captain MedicineRelease date:2024-12-19Recommended:188
Apelix is a commonly used drug that is widely used in a variety of health management fields. Proper use can help patients better achieve their treatment goals. Understanding how Ap···【more】
Article source:Captain MedicineRelease date:2024-12-19Recommended:174
Apelix is a drug that is widely used to treat immune system disorders and is of great concern to patients. When purchasing, understanding the price of Apelis, the features of the p···【more】
Article source:Captain MedicineRelease date:2024-12-18Recommended:193
Apellix, a commonly used drug, is widely used to treat diseases related to the immune system. Its price, purchase path and usage precautions are the focus of consumers' attenti···【more】
Article source:Captain MedicineRelease date:2024-12-18Recommended:239
Anagrelide is an important drug that plays an active role in clinical treatment. When used in combination with other drugs, there may be some interactions that affect the effective···【more】
Article source:Captain MedicineRelease date:2024-12-17Recommended:243
In the process of clinical treatment, the combination of drugs often leads to better efficacy. However, drug-drug interactions may also affect the effectiveness of treatment and ev···【more】
Article source:Captain MedicineRelease date:2024-12-17Recommended:245
Thrombocythemia is a common blood disease that poses a serious threat to the health of patients. Choosing the right treatment drug and following the correct dosage is the key to co···【more】
Article source:Captain MedicineRelease date:2024-12-16Recommended:185
Thrombocythemia is a common blood disorder, and drug therapy is one of the common treatments. Among the many drugs, anagrelide is widely used because of its remarkable efficacy. So···【more】
Article source:Captain MedicineRelease date:2024-12-16Recommended:167
Anagrelide is a drug used to treat idiopathic thrombocythemia, and its price fluctuates with the market, supply and demand, and manufacturers. Knowing the latest price of anagrelid···【more】
Article source:Captain MedicineRelease date:2024-12-13Recommended:179
Anagrelide is a medication commonly used to treat idiopathic thrombocythemia. As one of the important drugs for the treatment of this condition, the price of the drug has become th···【more】
Article source:Captain MedicineRelease date:2024-12-13Recommended:177
In the current medical market, the price fluctuation of anagrelide as a drug used to treat diseases such as polycythemia vera has attracted widespread attention. This article will ···【more】
Article source:Captain MedicineRelease date:2024-12-12Recommended:166
Anagrelide is a drug used to treat thrombocythemia, primarily for abnormal elevated platelet counts caused by essential thrombocythemia (ET) and other myeloproliferative conditions···【more】
Article source:Captain MedicineRelease date:2024-12-12Recommended:231
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1692025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4082024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1632025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1832025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1632025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1992025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1772025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1722025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: